Trial Data Transparency, Management Blog | TrialAssure

TrialAssure Achieves ISO 27001:2022 Certification as Demand Grows for Trusted AI in Drug Development

TrialAssure Achieves ISO 27001:2022 Certification as Demand Grows for Trusted AI in Drug Development

by Staff Writer | August 2026

Posted in Blog

Read More

TTrialAssure® ANONYMIZE® beside European flags.

TrialAssure® ANONYMIZE® Selected by the European Medicines Agency as Official Anonymisation Tool

by Don McLean | July 2026

Posted in Blog, News

Read More

Typing on a laptop

The Case of the 5 Review Copies – An AI Medical Writing Story

by James Greene | July 2026

Posted in Blog

Read More

TrialAssure and Cancer Research UK Collaborate

TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring

by Don McLean | June 2026

Posted in Blog, News

Read More

Dr. Oladayo Oyelola

Dr. Oladayo Oyelola Joins TrialAssure’s Advisory Board to Support Clinical Trial Transparency Strategy

by Don McLean | June 2026

Posted in Blog, News

Read More

Pill with DNA Strand

What AI Drug Discovery Can Teach Us About Responsible AI Across the Clinical Development Pipeline

by Staff Writer | June 2026

Posted in Blog

Read More

Helping Medical Writers Embrace AI Through Effective Change Management Artificial intelligence (AI) is rapidly changing the way clinical and regulatory content is developed across the pharmaceutical and biotechnology industry. The AI medical writing market alone is expected to surpass USD 1.7B by the year 2030, according to Grand View Research, and tools like TrialAssure LINK AI are helping organizations accelerate content generation, support consistency, reduce repetitive work, and improve collaboration across teams. At the same time, introducing AI into medical writing workflows can create understandable concerns among writers, reviewers, and cross-functional stakeholders. Questions around quality, compliance, authorship, job security, and trust naturally arise when new technology becomes part of the highly regulated drug development space. For organizations adopting AI-enabled medical writing platforms, success depends on more implementing and embracing software. To do this, it requires thoughtful change management centered around the people who will use these AI medical writing systems every day. “It’s important that medical writers should feel empowered, respected, and included throughout the transition,” shared James Greene, Executive Director of Growth & Partnerships at TrialAssure. “Companies that approach AI adoption collaboratively are far more likely to see strong engagement, faster adoption, and long-term success.”

Helping Medical Writers Embrace AI Through Effective Change Management

by Don McLean | May 2026

Posted in Blog

Read More

Feature image

Pharma AI Expert Zach Weingarden of TrialAssure Named a 2026 Crain’s Detroit Business Notable Leader in Health Care

by Don McLean | May 2026

Posted in Blog, News

Read More

Modernizing Federal Technology for a More Connected and Efficient Government | TrialAssure | missing clinical trial results FDA

FDA Flags Thousands of Missing Clinical Trial Results. Is Your Team Prepared?

by Don McLean | April 2026

Posted in Blog

Read More

TrialAssure Wins “Data Privacy Solution of the Year” for AI-Powered Anonymization and Redaction Platform CANTON, Mich. (April 16, 2026) – TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today that its TrialAssure ANONYMIZE product has been named Data Privacy Solution of the Year in the 2026 Data Breakthrough Awards program. TrialAssure ANONYMIZE supports data sharing and transparency initiatives by automatically identifying sensitive information, applying consistent anonymization rules, and providing full auditability for the pharmaceutical and biotechnology industry. | TrialAssure Wins Prestigious MichBusiness Triple Trusted Advisors Award for its Innovative AI Solutions

TrialAssure Wins “Data Privacy Solution of the Year” for AI-Powered Anonymization and Redaction Platform

by Staff Writer | April 2026

Posted in Blog, News

Read More

Get in Touch